The CYP 2C19*2 and CYP2C19*17 Polymorphisms Play a Vital Role in Platelet Responsiveness to Clopidogrel After Percutaneous Coronary Intervention: A Pharmacogenomic Study
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2015.05.146
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2015
Authors
Publisher
Elsevier BV